Introduction: Music therapy is one of the types of active ageing programmes which are offered to elderly people. The usefulness of this programme in the field of dementia is beginning to be recognised by the scientific community, since studies have reported physical, cognitive, and psychological benefits. Further studies detailing the changes resulting from the use…
Neurología (English Edition) Template
Write in a clean editor, then format for Neurología (English Edition) in one click — DocuGuru applies the official Elsevier template with numbered references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
About the Neurología (English Edition) format
Neurología (English Edition) is a peer-reviewed journal published by Elsevier, covering Acute Ischemic Stroke Management, Peripheral Neuropathies and Disorders, Multiple Sclerosis Research Studies.
| Publisher | Elsevier |
|---|---|
| Reference style | Numbered (Elsevier) Numbered — [1], [2] in the text [1] A. Smith, B. Jones, C. Lee, A representative article title, Neurología (English Edition) 12 (2023) 45–58.
Formats any DOI in Neurología (English Edition) style. No sign-up. |
| Publishes research in | Acute Ischemic Stroke Management Peripheral Neuropathies and Disorders Multiple Sclerosis Research Studies Epilepsy research and treatment Dementia and Cognitive Impairment Research |
| ISSN | 2173-5808 |
| Citation impact (2-yr) | 1.13 |
| h-index | 47 |
| i10-index | 450 |
| Total citations | 15,158 |
| Article processing charge | $1,941 |
| Open access | Yes |
| Top institutions publishing here | Hospital Clínico San Carlos |
| Journal website | www.journals.elsevier.com |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Papers published in Neurología (English Edition) per year
Citation impact of Neurología (English Edition) by publication year
Citations each year’s papers have accumulated so far — the most recent years are still building up.
Most-cited papers in Neurología (English Edition)
The neurotoxin 6-hydroxydopamine (6-OHDA) is widely used to induce models of Parkinson's disease (PD). We now know that the model induced by 6-OHDA does not include all PD symptoms, although it does reproduce the main cellular processes involved in PD, such as oxidative stress, neurodegeneration, neuroinflammation, and neuronal death by apoptosis. In this review we…